| Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy D Ciardiello, PP Vitiello, C Cardone, G Martini, T Troiani, E Martinelli, ... Cancer treatment reviews 76, 22-32, 2019 | 296 | 2019 |
| Precision oncology in metastatic colorectal cancer—from biology to medicine F Di Nicolantonio, PP Vitiello, S Marsoni, S Siena, J Tabernero, ... Nature reviews Clinical oncology 18 (8), 506-525, 2021 | 190 | 2021 |
| Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives E Martinelli, D Ciardiello, G Martini, T Troiani, C Cardone, PP Vitiello, ... Annals of Oncology 31 (1), 30-40, 2020 | 168 | 2020 |
| Cetuximab rechallenge plus avelumab in pretreated patients with RAS wild-type metastatic colorectal cancer: the phase 2 single-arm clinical CAVE trial E Martinelli, G Martini, V Famiglietti, T Troiani, S Napolitano, ... JAMA oncology 7 (10), 1529-1535, 2021 | 129 | 2021 |
| Present and future of metastatic colorectal cancer treatment: a review of new candidate targets G Martini, T Troiani, C Cardone, P Vitiello, V Sforza, D Ciardiello, ... World journal of gastroenterology 23 (26), 4675, 2017 | 116 | 2017 |
| Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines PP Vitiello, C Cardone, G Martini, D Ciardiello, V Belli, N Matrone, G Barra, ... Journal of Experimental & Clinical Cancer Research 38, 1-12, 2019 | 92 | 2019 |
| EPHA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer G Martini, C Cardone, PP Vitiello, V Belli, S Napolitano, T Troiani, ... Molecular Cancer Therapeutics 18 (4), 845-855, 2019 | 81 | 2019 |
| Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients G Crisafulli, A Sartore-Bianchi, L Lazzari, F Pietrantonio, A Amatu, ... Cancer discovery 12 (7), 1656-1675, 2022 | 80 | 2022 |
| Liquid biopsies to monitor and direct cancer treatment in colorectal cancer G Mauri, PP Vitiello, A Sogari, G Crisafulli, A Sartore-Bianchi, S Marsoni, ... British Journal of Cancer 127 (3), 394-407, 2022 | 72 | 2022 |
| Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells A Grimaldi, D Santini, S Zappavigna, A Lombardi, G Misso, M Boccellino, ... Cancer biology & therapy 16 (4), 567-579, 2015 | 67 | 2015 |
| Resistance to anti-epidermal growth factor receptor in metastatic colorectal cancer: what does still need to be addressed? G Martini, D Ciardiello, PP Vitiello, S Napolitano, C Cardone, A Cuomo, ... Cancer treatment reviews 86, 102023, 2020 | 49 | 2020 |
| Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience PP Vitiello, V De Falco, EF Giunta, D Ciardiello, C Cardone, P Vitale, ... Cancers 11 (10), 1504, 2019 | 46 | 2019 |
| Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case E Martinelli, T Troiani, V Sforza, G Martini, C Cardone, PP Vitiello, ... ESMO open 3 (1), e000299, 2018 | 40 | 2018 |
| Biomarker-guided anti-EGFR rechallenge therapy in metastatic colorectal cancer D Ciardiello, G Martini, V Famiglietti, S Napolitano, V De Falco, T Troiani, ... Cancers 13 (8), 1941, 2021 | 35 | 2021 |
| Changing paradigms in cranio-facial regeneration: current and new strategies for the activation of endogenous stem cells L Mele, PP Vitiello, V Tirino, F Paino, A De Rosa, D Liccardo, G Papaccio, ... Frontiers in Physiology 7, 62, 2016 | 33 | 2016 |
| Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer PP Vitiello, G Martini, L Mele, EF Giunta, V De Falco, D Ciardiello, V Belli, ... Journal of Experimental & Clinical Cancer Research 40, 1-15, 2021 | 25 | 2021 |
| Feasibility of next-generation sequencing in clinical practice: Results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’ V De Falco, L Poliero, PP Vitiello, D Ciardiello, P Vitale, N Zanaletti, ... ESMO open 5 (2), e000675, 2020 | 21 | 2020 |
| Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use … V Sforza, E Martinelli, C Cardone, G Martini, S Napolitano, PP Vitiello, ... ESMO open 2 (4), e000229, 2017 | 18 | 2017 |
| A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant V De Falco, MI Natalicchio, S Napolitano, N Coppola, G Conzo, ... Medicine 98 (21), e15759, 2019 | 15 | 2019 |
| Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology. O Gumusay, PP Vitiello, C Wabl, RB Corcoran, A Bardelli, HS Rugo American Society of Clinical Oncology Educational book. American Society of …, 2020 | 13 | 2020 |
Fortunato CiardielloProfessore di oncologia medica, seconda università di napoliGeverifieerd e-mailadres voor unina2.it
